{"title":"基因治疗用病毒载体的制造:第一部分:上游加工","authors":"O. Merten, M. Schweizer, P. Chahal, A. Kamen","doi":"10.4155/PBP.14.16","DOIUrl":null,"url":null,"abstract":"Manufacturing technologies for the production of clinical grade viral vectors have been significantly improved in recent years. This is of utmost importance for gene therapy approaches used in the treatment of inherited or acquired diseases. This article briefly describes the general principles for the production of viral vectors. The specific sections are dedicated to more detailed descriptions of the production of adenoviral, AAV, γ-retroviral and lentiviral vectors. A subsequent article (the second part) will then deal with downstream processing (purification) of viral vectors.","PeriodicalId":90285,"journal":{"name":"Pharmaceutical bioprocessing","volume":"2 1","pages":"183-203"},"PeriodicalIF":0.0000,"publicationDate":"2014-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4155/PBP.14.16","citationCount":"33","resultStr":"{\"title\":\"Manufacturing of viral vectors for gene therapy: part I. Upstream processing\",\"authors\":\"O. Merten, M. Schweizer, P. Chahal, A. Kamen\",\"doi\":\"10.4155/PBP.14.16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Manufacturing technologies for the production of clinical grade viral vectors have been significantly improved in recent years. This is of utmost importance for gene therapy approaches used in the treatment of inherited or acquired diseases. This article briefly describes the general principles for the production of viral vectors. The specific sections are dedicated to more detailed descriptions of the production of adenoviral, AAV, γ-retroviral and lentiviral vectors. A subsequent article (the second part) will then deal with downstream processing (purification) of viral vectors.\",\"PeriodicalId\":90285,\"journal\":{\"name\":\"Pharmaceutical bioprocessing\",\"volume\":\"2 1\",\"pages\":\"183-203\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-06-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4155/PBP.14.16\",\"citationCount\":\"33\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical bioprocessing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4155/PBP.14.16\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical bioprocessing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4155/PBP.14.16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Manufacturing of viral vectors for gene therapy: part I. Upstream processing
Manufacturing technologies for the production of clinical grade viral vectors have been significantly improved in recent years. This is of utmost importance for gene therapy approaches used in the treatment of inherited or acquired diseases. This article briefly describes the general principles for the production of viral vectors. The specific sections are dedicated to more detailed descriptions of the production of adenoviral, AAV, γ-retroviral and lentiviral vectors. A subsequent article (the second part) will then deal with downstream processing (purification) of viral vectors.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
